After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
TheStreet highlights 3 stocks pushing the drugs industry higher today.
Abbott’s (ABT) stock price target was increased to $50 from $48 at Barclays following the company’s 2016 second quarter results.
The medical device company has two pending acquisitions worth just under $40 billion combined.
The company reported flat but in line earnings of $1.06 per share.
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.